Cushing’s Disease Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: C4BB7D0200FFEN
Market Monitor Global

Abstracts

Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.

This report contains market size and forecasts of Cushing’s Disease Treatment in Global, including the following market information:

Global Cushing’s Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cushing’s Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Ketoconazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cushing’s Disease Treatment include CORCEPT THERAPEUTICS, HRA Pharma, Strongbridge Biopharma and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cushing’s Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cushing’s Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cushing’s Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Ketoconazole
• Mitotane
• Aminoglutethimide
• Metyrapone
• Mifepristone
• Etomidate
• Pasireotide

Global Cushing’s Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cushing’s Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Clinics
• E-Commerce/Online Pharmacies

Global Cushing’s Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cushing’s Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cushing’s Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cushing’s Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CORCEPT THERAPEUTICS
• HRA Pharma
• Strongbridge Biopharma
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cushing’s Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cushing’s Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CUSHING’S DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Cushing’s Disease Treatment Market Size: 2021 VS 2028
2.2 Global Cushing’s Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cushing’s Disease Treatment Players in Global Market
3.2 Top Global Cushing’s Disease Treatment Companies Ranked by Revenue
3.3 Global Cushing’s Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Cushing’s Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cushing’s Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cushing’s Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Cushing’s Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cushing’s Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cushing’s Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Ketoconazole
  4.1.3 Mitotane
  4.1.4 Aminoglutethimide
  4.1.5 Metyrapone
  4.1.6 Mifepristone
  4.1.7 Etomidate
  4.1.8 Pasireotide
4.2 By Type - Global Cushing’s Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Cushing’s Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Cushing’s Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Cushing’s Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cushing’s Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Drug Stores
  5.1.5 Clinics
  5.1.6 E-Commerce/Online Pharmacies
5.2 By Application - Global Cushing’s Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Cushing’s Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Cushing’s Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Cushing’s Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cushing’s Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Cushing’s Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Cushing’s Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Cushing’s Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Cushing’s Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cushing’s Disease Treatment Revenue, 2017-2028
  6.3.2 US Cushing’s Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Cushing’s Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Cushing’s Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cushing’s Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Cushing’s Disease Treatment Market Size, 2017-2028
  6.4.3 France Cushing’s Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Cushing’s Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Cushing’s Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Cushing’s Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Cushing’s Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Cushing’s Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cushing’s Disease Treatment Revenue, 2017-2028
  6.5.2 China Cushing’s Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Cushing’s Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Cushing’s Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Cushing’s Disease Treatment Market Size, 2017-2028
  6.5.6 India Cushing’s Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cushing’s Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Cushing’s Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Cushing’s Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cushing’s Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Cushing’s Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Cushing’s Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Cushing’s Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Cushing’s Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 CORCEPT THERAPEUTICS
  7.1.1 CORCEPT THERAPEUTICS Corporate Summary
  7.1.2 CORCEPT THERAPEUTICS Business Overview
  7.1.3 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Major Product Offerings
  7.1.4 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 CORCEPT THERAPEUTICS Key News
7.2 HRA Pharma
  7.2.1 HRA Pharma Corporate Summary
  7.2.2 HRA Pharma Business Overview
  7.2.3 HRA Pharma Cushing’s Disease Treatment Major Product Offerings
  7.2.4 HRA Pharma Cushing’s Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 HRA Pharma Key News
7.3 Strongbridge Biopharma
  7.3.1 Strongbridge Biopharma Corporate Summary
  7.3.2 Strongbridge Biopharma Business Overview
  7.3.3 Strongbridge Biopharma Cushing’s Disease Treatment Major Product Offerings
  7.3.4 Strongbridge Biopharma Cushing’s Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Strongbridge Biopharma Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Cushing’s Disease Treatment Major Product Offerings
  7.4.4 Novartis Cushing’s Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cushing’s Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Cushing’s Disease Treatment Market Drivers in Global Market
Table 3. Cushing’s Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Cushing’s Disease Treatment in Global Market
Table 5. Top Cushing’s Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cushing’s Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cushing’s Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cushing’s Disease Treatment Product Type
Table 9. List of Global Tier 1 Cushing’s Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cushing’s Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cushing’s Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cushing’s Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cushing’s Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cushing’s Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cushing’s Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cushing’s Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cushing’s Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cushing’s Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cushing’s Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cushing’s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cushing’s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cushing’s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cushing’s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cushing’s Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. CORCEPT THERAPEUTICS Corporate Summary
Table 31. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Product Offerings
Table 32. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. HRA Pharma Corporate Summary
Table 34. HRA Pharma Cushing’s Disease Treatment Product Offerings
Table 35. HRA Pharma Cushing’s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Strongbridge Biopharma Corporate Summary
Table 37. Strongbridge Biopharma Cushing’s Disease Treatment Product Offerings
Table 38. Strongbridge Biopharma Cushing’s Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Cushing’s Disease Treatment Product Offerings
Table 41. Novartis Cushing’s Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cushing’s Disease Treatment Segment by Type in 2021
Figure 2. Cushing’s Disease Treatment Segment by Application in 2021
Figure 3. Global Cushing’s Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cushing’s Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cushing’s Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cushing’s Disease Treatment Revenue in 2021
Figure 8. By Type - Global Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cushing’s Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cushing’s Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. CORCEPT THERAPEUTICS Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. HRA Pharma Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Strongbridge Biopharma Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Cushing’s Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)